Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
EryPharm logo — EryPharm developed a mass production process for cultured re...

EryPharm

EryPharm developed a mass production process for cultured red blood cells as a transfusion product.

Founded 2016 France France 4 employees Unknown

General Information

Company Name EryPharm
Founded Year 2016
Location France France +1
Employees 4
Funding Stage Unknown
Social

Get notified when EryPharm moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About EryPharm

EryPharm, founded in 2016, is a pioneering biotech startup headquartered in France. The company has developed an innovative large-scale process for producing cultured red blood cells from stem cells, a project initially spearheaded by Dr. Luc Douay and his team at the Paris Sorbonne University.

EryPharm’s technology presents a breakthrough in the field of transfusion products, potentially reshaping the landscape of blood supply. Their approach addresses the perennial challenge of blood donation shortages, proposing a reliable and sustainable alternative.

The company received a seed round investment of €16.38M in July 2016, backed by investors AGORANOV and Corely. Given the foundational technology and significant early investment, EryPharm stands as a compelling prospect for further rounds of financing. This positions them well to escalate their production capabilities and drive market entry in the biotechnology sector.

Taxonomy: Biotech, Stem Cell Technology, Blood Transfusion, Cultured Red Blood Cells, Therapeutic Products, Medical Innovation, Biomedical Engineering, Life Sciences, Research and Development

Services & Products

Mass production of cultured red blood cells
Development of new blood transfusion products
Innovative biotechnological approaches

Target Customers

Patients with hereditary blood disorders Cancer patients requiring multiple transfusions Healthcare providers Medical research facilities

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Spinout •••••• 1
Investor
01 Aug 2016

EryPharm Alternatives & Competitors

View All Alternatives
EryPharm vs
dNovo Bio
dNovo Bio United States

Towards the Cure for Hair Loss

Seed
3 employees
Biotechnology, Health Care
EryPharm vs
Cells4Life Group LLP
Cells4Life Group LLP United Kingdom

We are the biggest private stem cell bank in the United Kingdom, storing more UK samples than any ot...

26 employees
Health Care
EryPharm vs
BioBridge Global
BioBridge Global United States

Our mission is to save and enhance lives through the healing power of human cells and tissue.

287 employees
Health Care
View all alternatives

FAQ About EryPharm

EryPharm developed a mass production process for cultured red blood cells as a transfusion product.
EryPharm was founded in 2016.
EryPharm is headquartered in France.
EryPharm has approximately 4 employees.
EryPharm has completed 1 funding round. The latest funding stage is Unknown.
EryPharm offers: Mass production of cultured red blood cells, Development of new blood transfusion products, Innovative biotechnological approaches.
Top alternatives and competitors to EryPharm include dNovo Bio, Cells4Life Group LLP, BioBridge Global, IvyGene , RedC Biotech Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EryPharm and dNovo Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors EryPharm and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy